Lung :: Elevated pepsin levels may lead to rejection of lung transplants
Health is a unity and harmony within the mind, body and spirit which is unique to each person, and is as defined by that person. The level of wellness or health is, in part, determined by the ability to deal with and defend against stress. Health is determined by physiological, psychological, socio-cultural, spiritual, and developmental stage variables.
logo - spiritindia - Lung :: Elevated pepsin levels may lead to rejection of lung transplants
GMP-certified manufacturing consultant

Elevated pepsin levels may lead to rejection of lung transplants

Lung :: Elevated pepsin levels may lead to rejection of lung transplants

Lung :: Elevated pepsin levels may lead to rejection of lung transplants

Researchers in the United Kingdom have demonstrated that high levels of pepsin, a digestive enzyme that is a marker for gastric aspiration, are associated with acute rejection of a lung transplant.

This research provides further evidence that lung rejection may be caused by factors other than alloimmunity, the attack the body mounts to protect itself against ?foreign? cells.

?We think gastric aspiration [the taking of stomach fluids into the lung] may contribute to an overall injury to the transplanted lung,? said Chris Ward, Ph.D., lead author of the study. ?This pattern of injury may be similar to rejection or increase the risk for further rejection.?

Dr. Ward, of Newcastle University, and the other researchers reported their findings in the June 15, 2007, issue of American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.

The study included 36 lung transplant recipients, 17 subjects with normal lung function but unexplained cough who served as ?disease controls? for the study, and 4 normal, nonsmoking control subjects. The researchers determined pepsin levels in all the subjects using bronchoalveolar lavage (BAL)

?Our primary finding was that, compared with control subjects,? wrote the researchers, ?BAL pepsin levels were elevated in stable lung transplant recipients, subjects with acute rejection, and subjects with bronciolitis obliterans [a common manifestation of lung transplant rejecton]. Our secondary finding was that the highest levels of pepsin appeared in the transplant recipients with clinically significant acute rejection (grade A2 or greater).?

These findings support the growing recognition that gastroesophageal reflux (GER) is a potential cause for post-transplant lung injury and other airway and lung diseases. Although none of the transplant patients were formally evaluated for GER, nearly all were treated with acid suppression medications, which is standard therapy after lung transplantation.

Despite those medications, known as proton pump inhibitors, the researchers found evidence of gastric aspiration. ?It is important to recognize that proton pump inhibitors do not prevent reflux per se, but rather act to cut down on acidic reflux,? the researchers noted. They also noted, that in addition to the damage that might be done to the new lung by acid reflux, pepsin is not targeted by these drugs and may be a separate cause of lung injury.

The researchers reported that the ?disease control? group?those with normal lung function, but unexplained cough?did not have pepsin in their lungs, even when 10 of 17 were diagnosed during the study as having gastroesophageal reflux disease (GERD). ?A diagnosis of GERD does not mean that patients are refluxing out of the esophagus and hence aspirating,? they explained. ?Even if the refluxate reaches the upper airway, it is almost certainly cleared by a hyperactive cough reflex.?

In their article, the researchers note ongoing studies being done at Duke University that appear to show lung transplant patients who undergo fundoplication, a surgical procedure that strengthens the valve between the stomach and the esophagus, before the transplant have longer survival rates and delayed onset of bronchiolitis obliterans syndrome than those who do not.

If fundoplication is confirmed as a useful prophylaxis in preventing lung rejection, they write, ?markers of aspiration may contribute to identifying patients who might derive clinical benefit.?




(Lung :: Elevated pepsin levels may lead to rejection of lung transplants published at SpiritIndia on Friday, June 15, 2007)



Lung

Search more information on Lung, Lung books

Recently posted related articles on Lung :

  1. Lung Cancer :: Tumor genome analysis unveils new insights into lung cancer
  2. Lung Cancer :: Study identifies novel gene alterations in lung cancer
  3. Lung :: Treat all patients with rare lung disease to prevent stroke, say doctors
  4. Lung Cancer :: GSK's Hycamtin, topotecan capsules approved for treatment of small cell lung cancer
  5. Lung Cancer :: CSHL researchers discover three new genes that cause lung cancer
  6. Newborn :: Gene-chip studies provide new leads in treating lung disease of premature newborns
  7. Lung :: Genomic profiling of lung tumors helps doctors choose most effective treatment
  8. Lung Cancer :: Studies suggest key correlation between lung cancer subtype and treatment outcomes
  9. Lung Cancer :: Lilly's Alimta for Lung Cancer in Europe
  10. Lung Cancer :: Blood protein detects lung cancer at earliest stage

Most related articles:

- Lung :: Elevated pepsin levels may lead to rejection of lung transplants
- Lung Transplant :: Proteins may predict lung transplant rejection - 13.8
- Lung Transplant :: Data presented at ISHLT meeting confirm RNA analysis can identify rejection in lung transplant recip - 12.7
- Transplant :: XDx presents success with AlloMap molecular expression testing to international transplant community - 9.7
- Kidney Transplant :: Steroid-free medication lowers rejection rate for kidney transplants - 8.5
- Lung Transplant :: Primary graft dysfunction is risk factor for a later serious lung transplant problem - 8.4
- Lung Cancer :: Annual CT scan for lung cancer offers new hope - 8.3
- Lung Cancer :: Statins shown to prevent lung cancer - 8.3
- Lung Cancer :: Lung cancer cases more in non-smokers - 8.3
- Lung Cancer :: Passive smoke in workplace increases lung cancer risk - 8.3


Lung - recent related articles/news stories:

- Surgery remans an option for lung cancer patients
- Thalidomide does not improve survival in lung cancer
- Lilly's lung cancer drug Alimta is approved in US
- Soy, tofu, sprouts can improve COPD symptoms
- Vandetanib with docetaxel improve lung cancer survival

»»   Ankylosing Spondylitis :: Remicade in ankylosing spondylitis show improvement in spinal mobility & spinal inflammation
««   Colon Cancer :: Colon cancer proteins show promise for blood test






Tools
Daily calorie need
Homeo tips
Homeo softwares
Associations
NHMC Alumni
IFH
PHS
Vital Informer
Articles & news
Education
Homeo articles
Homeopathy cases
Homeopathic Remedies
You
Authors
Submit article
Your account
Testimonials
About
About us
Advertisers
Advertising
Linking us
Disclaimer
Privacy policy

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com